Last 12 months
Inside the activity.
0 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2019 Filed Mar 5, 2019 21:53 UTC |
Bonello WilliamChief Strategy Officer
|
GrantCommon Stock | 6,735 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-19-000027 · wf-form4_155182281921308.xml · nonDerivative · entry 1 Bonello William · CIK 0001454941 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,735 Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:47 UTC |
Weiss Lawrence MartinChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 36,022 | $19.60 Strike: $19.60 | $706,031.20 |
DisclosureSEC source: 0001077183-19-000025 · wf-form4_155182241852994.xml · derivative · entry 2 Weiss Lawrence Martin · CIK 0001761625 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,022 Underlying: Common Stock · 36,022 shares Expires 2024-03-01 F1 · derivative.exercise_date: On March 1, 2019, Dr. Weiss was granted an option to purchase shares of NeoGenomics, Inc. common stock. The option vests ratably over the first four anniversary dates of the grant date. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:47 UTC |
Weiss Lawrence MartinChief Scientific Officer
|
GrantCommon Stock | 5,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-19-000025 · wf-form4_155182241852994.xml · nonDerivative · entry 1 Weiss Lawrence Martin · CIK 0001761625 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,893 Read SEC document |
| February 28, 2019 Filed Feb 28, 2019 22:05 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 13,986 | $0.00 Strike: $7.15 | $0.00 |
DisclosureSEC source: 0001077183-19-000015 · wf-form4_155139154286590.xml · derivative · entry 7 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,666 Underlying: Common Stock · 13,986 shares Expires 2021-04-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On April 20, 2016, Mr. Shovlin was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| February 28, 2019 Filed Feb 28, 2019 22:05 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
Exercise / conversionCommon Stock | 13,986 | $7.15 | $99,999.90 |
DisclosureSEC source: 0001077183-19-000015 · wf-form4_155139154286590.xml · nonDerivative · entry 5 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,377 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 22:25 UTC |
BALLIET JENNIFERVP and Chief Culture Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001077183-19-000020 · wf-form4_155173830561711.xml · derivative · entry 8 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 20,000 shares Expires 2022-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On April 28, 2017, Ms. Balliet was granted 60,000 stock options. The options vest ratably over the first three anniversaries of the grant date. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 22:25 UTC |
BALLIET JENNIFERVP and Chief Culture Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001077183-19-000020 · wf-form4_155173830561711.xml · derivative · entry 7 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 10,000 shares Expires 2023-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On February 26, 2018, Ms. Balliet was granted 72,500 stock options which vested ratably over the first three anniversary dates of the grant date. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 22:25 UTC |
BALLIET JENNIFERVP and Chief Culture Officer
|
SaleCommon Stock | 30,000 | $19.57 | $587,100.00 |
DisclosureSEC source: 0001077183-19-000020 · wf-form4_155173830561711.xml · nonDerivative · entry 3 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · price: Average price of shares sold. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 22:25 UTC |
BALLIET JENNIFERVP and Chief Culture Officer
|
Exercise / conversionCommon Stock | 10,000 | $8.03 | $80,300.00 |
DisclosureSEC source: 0001077183-19-000020 · wf-form4_155173830561711.xml · nonDerivative · entry 2 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 22:25 UTC |
BALLIET JENNIFERVP and Chief Culture Officer
|
Exercise / conversionCommon Stock | 20,000 | $7.52 | $150,400.00 |
DisclosureSEC source: 0001077183-19-000020 · wf-form4_155173830561711.xml · nonDerivative · entry 1 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 01:25 UTC |
JONES STEVEN CDirector · Executive Vice President
|
SaleCommon Stock | 32,371 | $18.78 | $607,927.38 |
DisclosureSEC source: 0001077183-19-000018 · wf-form4_155140353500112.xml · nonDerivative · entry 4 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By self as Trustee for Steven and Carisa Jones 401k and Trust Disclosed balance after: 150,000 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 01:25 UTC |
JONES STEVEN CDirector · Executive Vice President
|
SaleCommon Stock | 252,881 | $18.90 | $4,779,450.90 |
DisclosureSEC source: 0001077183-19-000018 · wf-form4_155140353500112.xml · nonDerivative · entry 2 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,900,000 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 00:42 UTC |
CARDOZA GEORGEPresident, Pharma Services
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $3.45 Strike: $3.45 | $103,500.00 |
DisclosureSEC source: 0001077183-19-000016 · wf-form4_155140091066370.xml · derivative · entry 3 CARDOZA GEORGE · CIK 0001518734 · President, Pharma Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2019-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On March 5, 2014 Mr. Cardoza was granted an option to purchase 30,000 shares. These options vest ratably over the first three anniversary dates of the grant. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 00:42 UTC |
CARDOZA GEORGEPresident, Pharma Services
|
Exercise / conversionCommon Stock | 30,000 | $3.45 | $103,500.00 |
DisclosureSEC source: 0001077183-19-000016 · wf-form4_155140091066370.xml · nonDerivative · entry 1 CARDOZA GEORGE · CIK 0001518734 · President, Pharma Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The total includes 16,667 shares of unvested restricted stock that were previously reported in Table II. Read SEC document |
| February 27, 2019 Filed Feb 28, 2019 22:05 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
SaleCommon Stock | 44,135 | $19.23 | $848,716.05 |
DisclosureSEC source: 0001077183-19-000015 · wf-form4_155139154286590.xml · nonDerivative · entry 4 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,391 Read SEC document |
| February 26, 2019 Filed Mar 1, 2019 01:25 UTC |
JONES STEVEN CDirector · Executive Vice President
|
SaleCommon Stock | 1,000 | $19.24 | $19,240.00 |
DisclosureSEC source: 0001077183-19-000018 · wf-form4_155140353500112.xml · nonDerivative · entry 5 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned in IRA, custodian accounts, and trusts for the family of Steven Jones Disclosed balance after: 47,657 Read SEC document |
| February 26, 2019 Filed Mar 1, 2019 01:25 UTC |
JONES STEVEN CDirector · Executive Vice President
|
SaleCommon Stock | 1,900 | $19.27 | $36,613.00 |
DisclosureSEC source: 0001077183-19-000018 · wf-form4_155140353500112.xml · nonDerivative · entry 3 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By self as Trustee for Steven and Carisa Jones 401k and Trust Disclosed balance after: 182,371 Read SEC document |
| February 26, 2019 Filed Mar 1, 2019 01:25 UTC |
JONES STEVEN CDirector · Executive Vice President
|
SaleCommon Stock | 11,721 | $19.24 | $225,512.04 |
DisclosureSEC source: 0001077183-19-000018 · wf-form4_155140353500112.xml · nonDerivative · entry 1 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 2,152,881 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:05 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 66,666 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001077183-19-000015 · wf-form4_155139154286590.xml · derivative · entry 8 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,334 Underlying: Common Stock · 66,666 shares Expires 2022-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On April 28, 2017, Mr. Shovlin was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:05 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 119,348 | $0.00 Strike: $7.15 | $0.00 |
DisclosureSEC source: 0001077183-19-000015 · wf-form4_155139154286590.xml · derivative · entry 6 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,652 Underlying: Common Stock · 119,348 shares Expires 2021-04-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On April 20, 2016, Mr. Shovlin was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:05 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
SaleCommon Stock | 141,879 | $18.88 | $2,678,675.52 |
DisclosureSEC source: 0001077183-19-000015 · wf-form4_155139154286590.xml · nonDerivative · entry 3 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,526 Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:05 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
Exercise / conversionCommon Stock | 66,666 | $7.52 | $501,328.32 |
DisclosureSEC source: 0001077183-19-000015 · wf-form4_155139154286590.xml · nonDerivative · entry 2 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,405 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:05 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
Exercise / conversionCommon Stock | 119,348 | $7.15 | $853,338.20 |
DisclosureSEC source: 0001077183-19-000015 · wf-form4_155139154286590.xml · nonDerivative · entry 1 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,739 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:59 UTC |
Bonello WilliamChief Strategy Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,037 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001077183-19-000014 · wf-form4_155139117368318.xml · derivative · entry 5 Bonello William · CIK 0001454941 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,963 Underlying: Common Stock · 20,037 shares Expires 2022-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:59 UTC |
Bonello WilliamChief Strategy Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 40,166 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001077183-19-000014 · wf-form4_155139117368318.xml · derivative · entry 4 Bonello William · CIK 0001454941 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,334 Underlying: Common Stock · 40,166 shares Expires 2023-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:59 UTC |
Bonello WilliamChief Strategy Officer
|
SaleCommon Stock | 60,203 | $18.90 | $1,137,836.70 |
DisclosureSEC source: 0001077183-19-000014 · wf-form4_155139117368318.xml · nonDerivative · entry 3 Bonello William · CIK 0001454941 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:59 UTC |
Bonello WilliamChief Strategy Officer
|
Exercise / conversionCommon Stock | 20,037 | $7.52 | $150,678.24 |
DisclosureSEC source: 0001077183-19-000014 · wf-form4_155139117368318.xml · nonDerivative · entry 2 Bonello William · CIK 0001454941 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,203 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:59 UTC |
Bonello WilliamChief Strategy Officer
|
Exercise / conversionCommon Stock | 40,166 | $8.03 | $322,532.98 |
DisclosureSEC source: 0001077183-19-000014 · wf-form4_155139117368318.xml · nonDerivative · entry 1 Bonello William · CIK 0001454941 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:57 UTC |
HIPP RAYMOND RDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,333 | $0.00 Strike: $7.27 | $0.00 |
DisclosureSEC source: 0001077183-19-000013 · wf-form4_155139102644751.xml · derivative · entry 7 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,667 Underlying: Common Stock · 3,333 shares Expires 2022-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On May 25, 2017, Mr. Hipp was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:57 UTC |
HIPP RAYMOND RDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,556 | $0.00 Strike: $9.11 | $0.00 |
DisclosureSEC source: 0001077183-19-000013 · wf-form4_155139102644751.xml · derivative · entry 6 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,777 Underlying: Common Stock · 5,556 shares Expires 2021-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On July 28, 2016, Mr. Hipp was granted 8,333 stock options. The options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:57 UTC |
HIPP RAYMOND RDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $4.78 | $0.00 |
DisclosureSEC source: 0001077183-19-000013 · wf-form4_155139102644751.xml · derivative · entry 5 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2020-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On May 6, 2015, Mr. Hipp was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:57 UTC |
HIPP RAYMOND RDirector
|
SaleCommon Stock | 18,889 | $18.90 | $357,002.10 |
DisclosureSEC source: 0001077183-19-000013 · wf-form4_155139102644751.xml · nonDerivative · entry 4 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,580 Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:57 UTC |
HIPP RAYMOND RDirector
|
Exercise / conversionCommon Stock | 3,333 | $7.27 | $24,230.91 |
DisclosureSEC source: 0001077183-19-000013 · wf-form4_155139102644751.xml · nonDerivative · entry 3 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,469 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:57 UTC |
HIPP RAYMOND RDirector
|
Exercise / conversionCommon Stock | 5,556 | $9.11 | $50,615.16 |
DisclosureSEC source: 0001077183-19-000013 · wf-form4_155139102644751.xml · nonDerivative · entry 2 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:57 UTC |
HIPP RAYMOND RDirector
|
Exercise / conversionCommon Stock | 10,000 | $4.78 | $47,800.00 |
DisclosureSEC source: 0001077183-19-000013 · wf-form4_155139102644751.xml · nonDerivative · entry 1 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2018 Filed Dec 27, 2018 00:08 UTC |
Johnson Kevin CDirector
|
PurchaseCommon Stock | 26,000 | $11.60 | $301,600.00 |
DisclosureSEC source: 0001077183-18-000151 · wf-form4_154586929654412.xml · nonDerivative · entry 1 Johnson Kevin C · CIK 0001353436 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,866 Read SEC document |
| December 14, 2018 Filed Dec 14, 2018 21:05 UTC |
GENERAL ELECTRIC COFormer 10% Owner
GE Medical Systems Information Technologies, Inc.Former 10% Owner
|
SaleCommon stock, $0.001 par value per share ("Common Stock") | 10,835,145 | $12.00 | $130,021,740.00 |
DisclosureSEC source: 0000899243-18-031056 · doc4.xml · nonDerivative · entry 1 GENERAL ELECTRIC CO · CIK 0000040545 · Former 10% Owner GE Medical Systems Information Technologies, Inc. · CIK 0001662667 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · ownership.direct: The securities reported herein were previously owned directly by GE Medical Systems Information Technologies, Inc., which is a wholly owned subsidiary of General Electric Company. F1 · ownership.nature: The securities reported herein were previously owned directly by GE Medical Systems Information Technologies, Inc., which is a wholly owned subsidiary of General Electric Company. Read SEC document |
| December 12, 2018 Filed Dec 14, 2018 21:35 UTC |
Weiss Lawrence MartinChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $13.87 Strike: $13.87 | $346,750.00 |
DisclosureSEC source: 0001077183-18-000149 · wf-form4_154482329833504.xml · derivative · entry 1 Weiss Lawrence Martin · CIK 0001761625 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2023-12-12 F1 · derivative.exercise_date: On December 12, 2018, Dr. Weiss was granted an option to purchase shares of NeoGenomics, Inc. common stock. The option vests ratably over the first three anniversary dates of the grant date. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 18:33 UTC |
TETRAULT LYNN A.Director
|
SaleCommon Stock | 2,000 | $15.97 | $31,940.00 |
DisclosureSEC source: 0001077183-18-000121 · wf-form4_154282516716166.xml · nonDerivative · entry 2 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,234 Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 18:33 UTC |
TETRAULT LYNN A.Director
|
SaleCommon Stock | 11,000 | $16.00 | $176,000.00 |
DisclosureSEC source: 0001077183-18-000121 · wf-form4_154282516716166.xml · nonDerivative · entry 1 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,234 Read SEC document |
| November 15, 2018 Filed Nov 16, 2018 22:18 UTC |
TETRAULT LYNN A.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,333 | $0.00 Strike: $7.27 | $0.00 |
DisclosureSEC source: 0001077183-18-000119 · wf-form4_154240667556312.xml · derivative · entry 7 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,667 Underlying: Common Stock · 3,333 shares Expires 2022-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On May 25, 2017, Lynn Tetrault was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date. Read SEC document |
| November 15, 2018 Filed Nov 16, 2018 22:18 UTC |
TETRAULT LYNN A.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,555 | $0.00 Strike: $9.11 | $0.00 |
DisclosureSEC source: 0001077183-18-000119 · wf-form4_154240667556312.xml · derivative · entry 6 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,778 Underlying: Common Stock · 5,555 shares Expires 2021-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On July 28, 2016, Lynn Tetrault was granted 8,333 stock options. The options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| November 15, 2018 Filed Nov 16, 2018 22:18 UTC |
TETRAULT LYNN A.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $6.66 | $0.00 |
DisclosureSEC source: 0001077183-18-000119 · wf-form4_154240667556312.xml · derivative · entry 5 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2020-07-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On July 15, 2015, Lynn Tetrault was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date. Read SEC document |
| November 15, 2018 Filed Nov 16, 2018 22:18 UTC |
TETRAULT LYNN A.Director
|
Exercise / conversionCommon Stock | 3,333 | $7.27 | $24,230.91 |
DisclosureSEC source: 0001077183-18-000119 · wf-form4_154240667556312.xml · nonDerivative · entry 3 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2018 Filed Nov 16, 2018 22:18 UTC |
TETRAULT LYNN A.Director
|
Exercise / conversionCommon Stock | 5,555 | $9.11 | $50,606.05 |
DisclosureSEC source: 0001077183-18-000119 · wf-form4_154240667556312.xml · nonDerivative · entry 2 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2018 Filed Nov 16, 2018 22:18 UTC |
TETRAULT LYNN A.Director
|
Exercise / conversionCommon Stock | 10,000 | $6.66 | $66,600.00 |
DisclosureSEC source: 0001077183-18-000119 · wf-form4_154240667556312.xml · nonDerivative · entry 1 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2018 Filed Nov 15, 2018 00:30 UTC |
JONES STEVEN CDirector · Executive Vice President
|
SaleCommon Stock | 1,729 | $16.50 | $28,528.50 |
DisclosureSEC source: 0001077183-18-000117 · wf-form4_154224184012849.xml · nonDerivative · entry 8 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By self as Trustee for Steven and Carisa Jones 401k and Trust Disclosed balance after: 184,271 Read SEC document |
| November 14, 2018 Filed Nov 15, 2018 00:30 UTC |
JONES STEVEN CDirector · Executive Vice President
|
SaleCommon Stock | 3,824 | $16.50 | $63,096.00 |
DisclosureSEC source: 0001077183-18-000117 · wf-form4_154224184012849.xml · nonDerivative · entry 3 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 2,164,602 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| November 14, 2018 Filed Nov 16, 2018 22:18 UTC |
TETRAULT LYNN A.Director
|
SaleCommon Stock | 5,000 | $16.16 | $80,800.00 |
DisclosureSEC source: 0001077183-18-000119 · wf-form4_154240667556312.xml · nonDerivative · entry 4 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,234 Read SEC document |
| November 13, 2018 Filed Nov 14, 2018 01:40 UTC Amendment |
BALLIET JENNIFERVP and Chief Culture Officer
|
GrantCommon Stock | 6,678 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-18-000113 · wf-form4a_154215960122504.xml · nonDerivative · entry 1 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · shares: This amended Form 4 reflects a correction to the amount of common stock holdings reported on the Form 4 filed on 5/31/2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.